Literature DB >> 29144826

Cataract Surgery in Patients with Diabetes: Management Strategies.

Scott R Peterson1,2, Paolo A Silva1,2, Timothy J Murtha1,2, Jennifer K Sun1,2.   

Abstract

Diabetes is a chronic systemic disease that affects nearly one in eight adults worldwide. Ocular complications, such as cataract, can lead to significant visual impairment. Among the worldwide population, cataract is the leading cause of blindness, and patients with diabetes have an increased incidence of cataracts which mature earlier compared to the rest of the population. Cataract surgery is a common and safe procedure, but can be associated with vision-threatening complications in the diabetic population, such as diabetic macular edema, postoperative macular edema, diabetic retinopathy progression, and posterior capsular opacification. This article is a brief review of diabetic cataract and complications associated with cataract extraction in this population of patients.

Entities:  

Keywords:  Cataract; diabetic macular edema; diabetic retinopathy

Mesh:

Year:  2017        PMID: 29144826     DOI: 10.1080/08820538.2017.1353817

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  15 in total

Review 1.  Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

2.  Visual outcomes after cataract surgery in patients with type 2 diabetes.

Authors:  Liyan Liu; Lisa J Herrinton; Stacey Alexeeff; Andrew J Karter; Laura B Amsden; James Carolan; Neal H Shorstein
Journal:  J Cataract Refract Surg       Date:  2019-01-09       Impact factor: 3.351

Review 3.  Cataract Surgery Considerations for Diabetic Patients.

Authors:  Jonathan A Go; Christina A Mamalis; Sumitra S Khandelwal
Journal:  Curr Diab Rep       Date:  2021-12-30       Impact factor: 4.810

4.  LncRNA GAS5 regulates migration and epithelial-to-mesenchymal transition in lens epithelial cells via the miR-204-3p/TGFBR1 axis.

Authors:  Xiao Li; Miaomiao Sun; Anran Cheng; Guangying Zheng
Journal:  Lab Invest       Date:  2021-12-16       Impact factor: 5.662

5.  Ferulic Acid Protects Human Lens Epithelial Cells against Ionizing Radiation-Induced Oxidative Damage by Activating Nrf2/HO-1 Signal Pathway.

Authors:  Yueqin Chen; Lei Zhu; Hu Meng; Xiangdong Sun; Chunyan Xue
Journal:  Oxid Med Cell Longev       Date:  2022-05-10       Impact factor: 7.310

6.  Effect of thioltransferase on oxidative stress induced by high glucose and advanced glycation end products in human lens epithelial cells.

Authors:  Qing Liu; Xu Wang; Hong Yan
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

7.  Diabetes and diabetic retinopathy in patients undergoing cataract surgery: a prevalence study-DiCat study report #2.

Authors:  Tommaso Rossi; Giacomo Panozzo; Giulia Della Mura; Diana Giannarelli; Daniele Ferrari; Giovanni Alessio; Carmela Palmisano; Serena Telani; Guido Ripandelli
Journal:  Acta Diabetol       Date:  2020-01-07       Impact factor: 4.280

8.  Protective effect of syringic acid via restoring cells biomechanics and organelle structure in human lens epithelial cells.

Authors:  Rong Yang; Xue Li; Jie Mei; Wencheng Wan; Xinduo Huang; Qiaohong Yang; Xiaoyong Wei
Journal:  J Bioenerg Biomembr       Date:  2021-03-11       Impact factor: 2.945

9.  Simvastatin alleviates epithelial-mesenchymal transition and oxidative stress of high glucose-induced lens epithelial cells in vitro by inhibiting RhoA/ROCK signaling.

Authors:  Jianming Fu; Xiaojie Hu
Journal:  Exp Ther Med       Date:  2022-04-29       Impact factor: 2.447

10.  Racemization in cataractous lens from diabetic and aging individuals: analysis of Asp 58 residue in αA-crystallin.

Authors:  Xiang-Jia Zhu; Ke-Ke Zhang; Wen-Wen He; Jiao Qi; Yi Lu
Journal:  Aging (Albany NY)       Date:  2021-06-07       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.